Simplex Trading
SRPT icon

Simplex Trading’s Sarepta Therapeutics SRPT Stock Holding History

Simplex Trading’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.93M Sell
272,700
-335,300
-55% -$6.49M ﹤0.01% 998
2025
Q4 		$13.1M Buy
608,000
+60,600
+11% +$1.28M 0.01% 713
2025
Q3 		$10.5M Buy
547,400
+77,900
+17% +$1.39M 0.01% 936
2025
Q2 		$8.03M Buy
469,500
+416,300
+783% +$17.8M ﹤0.01% 1030
2025
Q1 		$3.4M Sell
53,200
-23,500
-31% -$2.47M ﹤0.01% 1565
2024
Q4 		$9.32M Sell
76,700
-100
-0.1% -$12.3K 0.01% 1076
2024
Q3 		$9.59M Sell
76,800
-38,100
-33% -$5.27M 0.01% 1064
2024
Q2 		$18.2M Sell
114,900
-69,300
-38% -$8.9M 0.01% 666
2024
Q1 		$23.8M Sell
184,200
-347,500
-65% -$42.6M 0.01% 605
2023
Q4 		$51.3M Buy
531,700
+295,500
+125% +$28.3M 0.03% 334
2023
Q3 		$28.6M Buy
236,200
+34,300
+17% +$3.88M 0.02% 451
2023
Q2 		$23.1M Buy
201,900
+33,400
+20% +$4.31M 0.02% 521
2023
Q1 		$23.2M Buy
168,500
+56,900
+51% +$7.38M 0.02% 529
2022
Q4 		$14.5M Buy
111,600
+23,500
+27% +$2.72M 0.02% 692
2022
Q3 		$9.74M Buy
88,100
+62,400
+243% +$6.29M 0.01% 817
2022
Q2 		$1.93M Sell
25,700
-21,600
-46% -$1.59M ﹤0.01% 1910
2022
Q1 		$3.69M Sell
47,300
-60,000
-56% -$4.59M ﹤0.01% 1506
2021
Q4 		$9.66M Buy
107,300
+74,800
+230% +$6.39M 0.01% 800
2021
Q3 		$2.54M Sell
32,500
-200
-0.6% -$15.4K ﹤0.01% 1858
2021
Q2 		$2.54M Buy
+32,700
New +$2.48M ﹤0.01% 1862
2021
Q1 		– Sell
-1,104
Closed -$18.8M – 9959
2020
Q4 		$18.8M Buy
1,104
+591
+115% +$87.6K 0.02% 371
2020
Q3 		$7.2M Buy
513
+50
+11% +$7.6K 0.01% 669
2020
Q2 		$7.42M Buy
463
+49
+12% +$6.67K 0.01% 644
2020
Q1 		$4.05M Sell
414
-809
-66% -$92.5K 0.01% 811
2019
Q4 		$15.8M Buy
1,223
+563
+85% +$56.8K 0.03% 336
2019
Q3 		$4.97M Sell
660
-29
-4% -$3.42K 0.01% 723
2019
Q2 		$10.5M Buy
689
+131
+23% +$15.9K 0.03% 393
2019
Q1 		$6.65M Sell
558
-101
-15% -$13K 0.02% 543
2018
Q4 		$7.19M Buy
659
+62
+10% +$7.75K 0.02% 436
2018
Q3 		$9.64M Sell
597
-471
-44% -$64.4K 0.03% 375
2018
Q2 		$14.1M Buy
1,068
+823
+336% +$77.6K 0.06% 247
2018
Q1 		$416K Sell
245
-431
-64% -$28.7K 0.02% 808
2017
Q4 		$883K Sell
676
-1,210
-64% -$64.1K 0.04% 440
2017
Q3 		$1.04M Buy
1,886
+1,417
+302% +$56.6K 0.04% 358
2017
Q2 		$178K Sell
469
-455
-49% -$14.8K 0.01% 1269
2017
Q1 		$126K Sell
924
-1,784
-66% -$55.2K 0.01% 1549
2016
Q4 		$282K Sell
2,708
-375
-12% -$15.1K 0.02% 836
2016
Q3 		$5.25M Sell
3,083
-495
-14% -$15K 0.36% 40
2016
Q2 		$977K Buy
3,578
+1,747
+95% +$32.4K 0.07% 289
2016
Q1 		$473K Buy
1,831
+1,305
+248% +$22.8K 0.04% 471
2015
Q4 		$499K Sell
526
-76
-13% -$2.46K 0.04% 433
2015
Q3 		$353K Buy
602
+85
+16% +$2.88K 0.03% 583
2015
Q2 		$449K Buy
517
+314
+155% +$6.42K 0.04% 430
2015
Q1 		$23K Sell
203
-400
-66% -$5.33K ﹤0.01% 2221
2014
Q4 		$26K Buy
+603
New +$10.2K ﹤0.01% 1859

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Simplex Trading's SRPT Position: Q3 2024 in Review

Simplex Trading sold out of Sarepta Therapeutics (SRPT) in Q3 2024, closing a stake of 63,784 shares — an estimated $8.82M sold.

Simplex Trading first reported a position in SRPT in Q4 2014 and held it in 30 quarters. The position peaked at $10.1M in Q2 2024. 457 funds tracked by Wall St. Rank hold SRPT as of Q3 2024.

  • Simplex Trading reported no remaining Sarepta Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 63,784 Sarepta Therapeutics shares in Q3 2024, an estimated $8.82M.
  • Simplex Trading first reported a position in Sarepta Therapeutics in Q4 2014 and held it in 30 quarters.
  • Simplex Trading's Sarepta Therapeutics position peaked at $10.1M in Q2 2024.
  • 457 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.